Tag Archive: addition

Feb 06

The addition of evolocumab (Amgen, Thousand Oaks, CA) to a statin

The addition of evolocumab (Amgen, Thousand Oaks, CA) to a statin, compared with a statin alone, significantly lowered LDL–cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, according to the top-line results of the LAPLACE-2 study announced this week. The full results of LAPLACE–2 will be presented by Dr Jennifer Robinson (University of Iowa, …

Continue reading »